Hiroyuki Hata. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntibodies, Monoclonal, Humanized/pharmacologyAntibodies, Monoclonal, Humanized/therapeutic useBendamustine HydrochlorideBenzoquinones/pharmacologyBenzoquinones/therapeutic useClinical Trials as TopicDrug Discovery/trendsDrug Therapy, CombinationHeterocyclic Compounds/pharmacologyHeterocyclic Compounds/therapeutic useHumansHydroxamic Acids/pharmacologyHydroxamic Acids/therapeutic useLactams, Macrocyclic/pharmacologyLactams, Macrocyclic/therapeutic useMolecular Targeted Therapy/trendsMultiple Myeloma/drug therapyNitrogen Mustard Compounds/pharmacologyNitrogen Mustard Compounds/therapeutic useOligopeptides/pharmacologyOligopeptides/therapeutic useThalidomide/analogs & derivativesThalidomide/pharmacologyThalidomide/therapeutic useVorinostat
Substances: See more » Antibodies, Monoclonal, HumanizedBenzoquinonesHeterocyclic CompoundsHydroxamic AcidsLactams, MacrocyclicNitrogen Mustard CompoundsOligopeptideselotuzumabtanespimycinThalidomideVorinostatcarfilzomibBendamustine Hydrochloridepomalidomideplerixafor
Year: 2011 PMID: 21897065
Source DB: PubMed Journal: Rinsho Ketsueki ISSN: 0485-1439